{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:51:05Z","timestamp":1761663065236,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"3-5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jsbmb.2012.05.008","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T22:45:22Z","timestamp":1338504322000},"page":"195-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Zoledronic acid inhibits aromatase activity and phosphorylation: Potential mechanism for additive zoledronic acid and letrozole drug interaction"],"prefix":"10.1016","volume":"132","author":[{"given":"Amanda J.","family":"Schech","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon E.","family":"Nemieboka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela H.","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jsbmb.2012.05.008_bib0005","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1093\/annonc\/mdq217","article-title":"Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study","volume":"21","author":"Eidtmann","year":"2010","journal-title":"Annals of Oncology"},{"issue":"7","key":"10.1016\/j.jsbmb.2012.05.008_bib0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1470-2045(11)70122-X","article-title":"Austrian breast and colorectal cancer study group, Vienna, Austria, adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial","volume":"12","author":"Gnant","year":"2011","journal-title":"The Lancet Oncology"},{"issue":"5","key":"10.1016\/j.jsbmb.2012.05.008_bib0015","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/cncr.26313","article-title":"Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole","volume":"118","author":"Brufsky","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jsbmb.2012.05.008_bib0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1634\/theoncologist.9-6-687","article-title":"Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy","volume":"9","author":"Vogel","year":"2004","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.jsbmb.2012.05.008_bib0025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/sj.bjc.6602551","article-title":"Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration","volume":"92","author":"Wardley","year":"2005","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.jsbmb.2012.05.008_bib0030","doi-asserted-by":"crossref","unstructured":"R.E. Coleman, H.C. Thorpe, D. Cameron, D. Dodwell, R. Burkinshaw, M. Keane, M. Gil, S.J. Houston, R.J. Grieve, P.J. Barrett-Lee, D. Ritchie, C. Davies, R. Bell, Adjuvant Treatment with Zoledronic Acid in Stage II\/III Breast Cancer. The AZURE Trial (BIG 01\/04), 2010.","DOI":"10.1158\/0008-5472.SABCS10-S4-5"},{"issue":"8","key":"10.1016\/j.jsbmb.2012.05.008_bib0035","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1054\/bjoc.1999.1131","article-title":"Bisphosphonates induce apoptosis in human breast cancer cell lines","volume":"82","author":"Senaratne","year":"2000","journal-title":"British Journal of Cancer"},{"issue":"11","key":"10.1016\/j.jsbmb.2012.05.008_bib0040","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1359\/jbmr.2000.15.11.2211","article-title":"Bisphosphonates induce breast cancer cell death in vitro","volume":"15","author":"Fromigue","year":"2000","journal-title":"Journal of Bone and Mineral Research"},{"issue":"8","key":"10.1016\/j.jsbmb.2012.05.008_bib0045","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1054\/bjoc.2001.1727","article-title":"The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel","volume":"84","author":"Jagdev","year":"2001","journal-title":"British Journal of Cancer"},{"issue":"9","key":"10.1016\/j.jsbmb.2012.05.008_bib0050","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.bjc.6600297","article-title":"The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells","volume":"86","author":"Senaratne","year":"2002","journal-title":"British Journal of Cancer"},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2012.05.008_bib0055","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.canlet.2006.03.011","article-title":"Differential effects of bisphosphonates on breast cancer cell lines","volume":"246","author":"Verdijk","year":"2007","journal-title":"Cancer Letters"},{"key":"10.1016\/j.jsbmb.2012.05.008_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/1477-3163.75723","article-title":"Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers","volume":"10","author":"Almubarak","year":"2011","journal-title":"Journal of Carcinogenesis"},{"issue":"1","key":"10.1016\/j.jsbmb.2012.05.008_bib0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.ju.0000070685.34760.5f","article-title":"Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells","volume":"170","author":"Oades","year":"2003","journal-title":"Journal of Urology"},{"issue":"7","key":"10.1016\/j.jsbmb.2012.05.008_bib0070","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0898-6568(03)00007-X","article-title":"Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway","volume":"15","author":"Iguchi","year":"2003","journal-title":"Cell Signalling"},{"issue":"6","key":"10.1016\/j.jsbmb.2012.05.008_bib0075","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/sj.bjc.6605579","article-title":"Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction","volume":"102","author":"Neville-Webbe","year":"2010","journal-title":"British Journal of Cancer"},{"issue":"21","key":"10.1016\/j.jsbmb.2012.05.008_bib0080","first-page":"6949","article-title":"Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening","volume":"50","author":"Zhou","year":"1990","journal-title":"Cancer Research"},{"issue":"22","key":"10.1016\/j.jsbmb.2012.05.008_bib0085","first-page":"8037","article-title":"Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens","volume":"63","author":"Thiantanawat","year":"2003","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.jsbmb.2012.05.008_bib0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0960-0760(98)00122-8","article-title":"The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity","volume":"67","author":"Long","year":"1998","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"8","key":"10.1016\/j.jsbmb.2012.05.008_bib0095","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1210\/me.2004-0388","article-title":"Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter","volume":"19","author":"Kazi","year":"2005","journal-title":"Molecular Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2012.05.008_bib0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1095\/biolreprod.109.076117","article-title":"Estrogen rapidly activates the PI3K\/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus","volume":"81","author":"Kazi","year":"2009","journal-title":"Biology of Reproduction"},{"issue":"6","key":"10.1016\/j.jsbmb.2012.05.008_bib0105","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/endo-100-6-1684","article-title":"The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer","volume":"100","author":"Brodie","year":"1977","journal-title":"Endocrinology"},{"issue":"3\u20135","key":"10.1016\/j.jsbmb.2012.05.008_bib0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0960-0760(03)00366-2","article-title":"Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways","volume":"86","author":"Yue","year":"2003","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"1\u20133","key":"10.1016\/j.jsbmb.2012.05.008_bib0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2008.09.001","article-title":"Aromatase is phosphorylated in situ at serine-118","volume":"112","author":"Miller","year":"2008","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"10","key":"10.1016\/j.jsbmb.2012.05.008_bib0120","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1210\/me.2009-0039","article-title":"Rapid estradiol\/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells","volume":"23","author":"Catalano","year":"2009","journal-title":"Molecular Endocrinology"},{"issue":"7","key":"10.1016\/j.jsbmb.2012.05.008_bib0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa0806285","article-title":"ABCSG-12 Trial Investigators, C. Marth, Endocrine therapy plus zoledronic acid in premenopausal breast cancer","volume":"360","author":"Gnant","year":"2009","journal-title":"New England Journal of Medicine"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076012001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076012001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:41:02Z","timestamp":1760744462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076012001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":25,"journal-issue":{"issue":"3-5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0960076012001045"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2012.05.008","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zoledronic acid inhibits aromatase activity and phosphorylation: Potential mechanism for additive zoledronic acid and letrozole drug interaction","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2012.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}